[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336173-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336173-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","shaping-oncogenic-microenvironments-contribution-of-fibronectin","Shaping Oncogenic Microenvironments: Contribution of Fibronectin","","The extracellular matrix (ECM) is dynamically remodeled during cancer progression, where basal lamina disruption, vascular invasion, and tumor-associated fibrosis increase tissue stiffness. This rigidity drives aberrant mechanotransduction that potentiates tumor cell de-differentiation, proliferation, and invasion. Fibrotic microenvironments are mainly secreted and assembled by non-cancerous cells, especially cancer-associated fibroblasts (CAFs), which produce fibronectin with type I collagen. This review examines the core interactions and signaling pathways through which fibronectin supports tumorigenesis and metastasis, aiming to inform therapy response prediction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/shaping-oncogenic-microenvironments-contribution-of-fibronectin/336173/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/shaping-oncogenic-microenvironments-contribution-of-fibronectin/336173.png","ImageObject",300,407,{"name":42,"@type":43},"Ava Thompson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does ECM stiffness increase during cancer progression?","Question",{"text":63,"@type":64},"Cancer progression involves extensive ECM remodeling with disruption of the basal lamina, endothelial invasion, and fibrosis around tumor cells. The resulting rigidity enhances mechanotransduction that supports malignant transformation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role do cancer-associated fibroblasts (CAFs) play in fibronectin production?",{"text":68,"@type":64},"CAFs are major producers of fibronectin in tumor stroma. They originate from resident fibroblasts under tumor stimuli, express high αSMA, and exert contractile forces and focal proteolysis to remodel and stiffen the ECM.",{"name":70,"@type":61,"acceptedAnswer":71},"How can fibronectin contribute to tumor metastasis?",{"text":72,"@type":64},"Fibronectin is described as a constant presence during matrix remodeling, including in pre-metastatic niches and migration tracks used by metastatic cells. The review connects fibronectin structure, signaling, and fibrotic microenvironments to tumorigenesis and metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336173,1790192916,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","TYPE Review  \nPUBLISHED 10 April 2024  \nDOI 10.3389/fcell.2024.1363004  \nOPEN ACCESS  \nEDITED BY  \nKarin Pﬁsterer,  \nMedical University of Vienna, Austria  \nREVIEWED BY  \nDemitrios Vynios, University of Patras, Greece Michael Hahne,  \nInstitut National de la Santé et de la Recherche Médicale (INSERM), France  \n*CORRESPONDENCE  \nMercedes Costell,  \n mercedes. costell@uv. es  \n†These authors have contributed equally to this work  \nRECEIVED 29 December 2023  \nACCEPTED 25 March 2024  \nPUBLISHED 10 April 2024  \nCITATION  \nGuerrero-Barberà G, Burday N and Costell M (2024), Shaping Oncogenic Microenvironments: Contribution of Fibronectin.  \nFront. Cell Dev. Biol. 12:1363004 .  \ndoi: 10.3389/fcell.2024.1363004  \nCOPYRIGHT  \n© 2024 Guerrero-Barberà, Burday and Costell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nShaping Oncogenic Microenvironments: Contribution of Fibronectin  \nGemma Guerrero-Barberà†, Natalia Burday† and Mercedes Costell*  \nDepartament of Biochemistry and Molecular Biology, Institut Universitari de Biotecnologia i Biomedicina, Universitat de València, Valencia, Spain  \nThe extracellular matrix (ECM) is a complex network of proteins and glycans, dynamically remodeled and speciﬁcally tailored to the structure/function of each organ. The malignant transformation of cancer cells is determined by both cell intrinsic properties, such as mutations, and extrinsic variables, such as the mixture of surrounding cells in the tumor microenvironment and the biophysics of the ECM. During cancer progression, the ECM undergoes extensive remodeling, characterized by disruption of the basal lamina, vascular endothelial cell invasion, and development of ﬁbrosis in and around the tumor cells resulting in increased tissue stiffness. This enhanced rigidity leads to aberrant mechanotransduction and further malignant transformation potentiating the de-differentiation, proliferation and invasion of tumor cells. Interestingly, this ﬁbrotic microenvironment is primarily secreted and assembled by non-cancerous cells. Among them, the cancer-associated ﬁbroblasts (CAFs) play a central role. CAFs massively produce ﬁbronectin together with type I collagen. This review delves into the primary interactions and signaling pathways through which ﬁbronectin can support tumorigenesis and metastasis, aiming to provide critical molecular insights for better therapy response prediction.  \nKEYWORDS  \nﬁbronectin, cancer, extracellular matrix, mechanosignaling, alfa5 beta1 integrin, microenvironment  \nIntroduction  \nThe glycoprotein ﬁbronectin (FN) is particularly abundant in the microenvironment of malignant tumors (Castellani et al., 1986; Bae et al., 2013; Peng et al., 2022), is the ﬁrst extracellular matrix (ECM) protein found in speciﬁc pre-metastatic niches (Medeiros et al., 2020), is present in the migration tracks used by metastatic cells (Erdogan et al., 2017) and its transcription is induced by hypoxia conditions in certain tumors (Mao et al., 2023) . Consequently, FN is a constant presence during the process of matrix remodeling that occurs during solid tumor growth and metastatic foci formation. In these processes, the FN ﬁbrillar structure harboring other ECM components, along with the expression of both FN splice isoforms and FN modiﬁer and cross-linker enzymes, play critical roles in inﬂuencingangiogenesis, metastasis, and chemoresistance, thereby impacting the disease outcome. Expanding our comprehension of FN biology within tumors promises improved predictions of therapy responses. Furthermore, understanding these mechanisms has particular releva","cbCaiftrQJp2BUUm","https://ap.wps.com/l/cbCaiftrQJp2BUUm","pdf",2274215,15,"English","# Introduction\n# Fibronectin in malignant tumor microenvironments\n# CAF-derived fibronectin and ECM remodeling\n# Fibronectin signaling in tumorigenesis and metastasis","[{\"question\":\"Why does ECM stiffness increase during cancer progression?\",\"answer\":\"Cancer progression involves extensive ECM remodeling with disruption of the basal lamina, endothelial invasion, and fibrosis around tumor cells. The resulting rigidity enhances mechanotransduction that supports malignant transformation.\"},{\"question\":\"What role do cancer-associated fibroblasts (CAFs) play in fibronectin production?\",\"answer\":\"CAFs are major producers of fibronectin in tumor stroma. They originate from resident fibroblasts under tumor stimuli, express high αSMA, and exert contractile forces and focal proteolysis to remodel and stiffen the ECM.\"},{\"question\":\"How can fibronectin contribute to tumor metastasis?\",\"answer\":\"Fibronectin is described as a constant presence during matrix remodeling, including in pre-metastatic niches and migration tracks used by metastatic cells. The review connects fibronectin structure, signaling, and fibrotic microenvironments to tumorigenesis and metastasis.\"}]","Shaping Oncogenic Microenvironments: Contribution of Fibronectin | PDF",1790013978,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ed6014bcf71b90e0b8dc4b9a13caa07.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b50baa7173915c85382cc2c8c311ff2.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8f949566876b353d4e921379be48213.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6f02a997b3336726e97a63b360d014a.webp",980,1385]